What is Sunshine Biopharma Inc (SBFM) stock price today?

Sunshine Biopharma Inc (SBFM) currently trades at $0.96 per share. The stock has a market capitalization of $4.81M and a P/E ratio of —x.

Is SBFM stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Sunshine Biopharma Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Sunshine Biopharma Inc's revenue and earnings?

Sunshine Biopharma Inc has trailing twelve-month (TTM) revenue of $36.31M with profit margins of -16.50%. Earnings per share (EPS) is $-1.44.

SBFM

Sunshine Biopharma Inc

NASDAQ: SBFM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.96

-0.43% today

Updated 2026-04-30

Market cap

$4.81M

P/E ratio

—

P/S ratio

0.13x

EPS (TTM)

$-1.44

Dividend yield

—

52W range

$1 – $2

Volume

0.0M

Market cap

$4.81M

P/E ratio

—

P/S ratio

0.13x

EPS (TTM)

$-1.44

Dividend yield

—

52W range

$1 – $2

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.3

Growth

C+

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$5.60

+481.94%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -16.50%

- Negative free cash flow $-2.39M

- Revenue declining -10.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$4.35M	$24.09M	$34.87M	$36.31M	$36.31M
Net income	$-26.74M	$-4.51M	$-5.13M	$-5.98M	$-2.14M
EPS	—	—	—	—	$-1.44
Free cash flow	$-5.55M	$-9.56M	$-14.85M	$-5.51M	$-2.39M
Profit margin	-615.44%	-18.70%	-14.72%	-16.46%	-16.50%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SBFM	$4.81M	31	5.3	2.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Sunshine Biopharma Inc trades at $0.96. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $36.31M. with profit margins at -16.50%.

Frequently asked questions

What is Sunshine Biopharma Inc's stock price?

Sunshine Biopharma Inc (SBFM) trades at $0.96.

Is Sunshine Biopharma Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Sunshine Biopharma Inc (SBFM)?

The analyst target price is $5.60, representing +481.9% upside from the current price of $0.96.

What is Sunshine Biopharma Inc's revenue?

TTM revenue is $36.31M.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.13x

ROE-25.70%

Beta1.60

50D MA$1.08

200D MA$1.38

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SBFM vs LLY →SBFM vs JNJ →SBFM vs ABBV →Stock screener →